vTv Therapeutics Inc.
Status: Publicly traded
Direct answer
vTv Therapeutics Inc. is publicly traded on NASDAQ under the ticker VTVT.
vTv Therapeutics Inc. is a biopharmaceutical company in the clinical development stage, primarily focused on creating orally administered treatments, with a significant emphasis on diabetes. Its pipeline features lead candidates such as TTP399, an oral, small-molecule, liver-specific glucokinase activator targeting Type 1 diabetes. Another key investigational drug is HPP737, an oral phosphodiesterase type 4 (PDE4)...
Can you invest in vTv Therapeutics Inc.?
Yes. vTv Therapeutics Inc. trades publicly on NASDAQ as VTVT.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for vTv Therapeutics Inc.
Detailed equity research is provided by MarketSnap.